secwatch.observer — SEC 8-K summary
======================================

Issuer:     HeartSciences Inc. (HSCS)
CIK:        0001468492
Form:       8-K
Filed at:   2025-07-24T23:59:59+00:00
Accession:  0000950170-25-098346
Event type: earnings
Sentiment:  negative
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HeartSciences reports no FY2025 revenue, $1.1M cash; advances MyoVista platform
-------------------------------------------------------------------------------

- Zero revenue for fiscal year ended April 30, 2025; cash and equivalents $1.1M, shareholders' equity $0.2M.
- Raised $3.1M gross in Reg A+ offering post-year-end; converted $0.9M debt to equity.
- Launched MyoVista Insights cloud software platform in May 2025 at early adopter sites.
- MyoVista wavECG device nearing FDA 510(k) submission; CMS approved $128/test reimbursement for AI-ECG algorithms.
- FDA Breakthrough Device designation for aortic stenosis algorithm; 44 granted patents worldwide.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1468492/000095017025098346/0000950170-25-098346-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1468492/000095017025098346/hscs-20250724.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-098346

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer